F. Hoffmann-La Roche Ltd: Roche launches the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision medicine

Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcarePreparing DNA for sequencing libraries is complex

Related Keywords

Switzerland ,Japan ,United States ,America ,Nathalie Meetz ,Karl Mahler ,Sabine Borngr ,Gerard Tobin ,Bruno Eschli ,Birgit Masjost ,Thomas Schinecker ,Loren Kalm ,Laboratory Use ,Genentech ,European Parliament ,Research Use Only ,Roche Group ,Roche Group Media Relations ,Vitro Diagnostics ,General Laboratory Use ,World Health Organization Model Lists ,Essential Medicines ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Hoffmann ,Oche ,Aunches ,Revenio ,Edge ,System ,Simplify ,Automate ,Text ,Generation ,Sequencing ,Sample ,Preparation ,Educe ,Human ,Terror ,Advance ,Precision ,Medicine ,